INDICATIONS OF VASCULAR ENDOTHELIAL-CELL DYSFUNCTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:47
作者
BYRON, MA
ALLINGTON, MJ
CHAPEL, HM
MOWAT, AG
CEDERHOLMWILLIAMS, SA
机构
[1] JOHN RADCLIFFE HOSP,DEPT HAEMATOL,OXFORD OX3 9DU,ENGLAND
[2] JOHN RADCLIFFE HOSP,DEPT IMMUNOPATHOL,OXFORD OX3 9DU,ENGLAND
[3] NUFFIELD ORTHOPAED CTR,DEPT RHEUMATOL,OXFORD OX3 7LD,ENGLAND
关键词
D O I
10.1136/ard.46.10.741
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:741 / 745
页数:5
相关论文
共 24 条
[11]  
GREEN D, 1983, THROMB HAEMOSTASIS, V49, P144
[12]   ABNORMAL ENDOTHELIAL RELEASE OF FIBRINOLYTIC-ACTIVITY AND FIBRONECTIN IN DIABETIC MICROANGIOPATHY [J].
HAITAS, B ;
BARNES, AJ ;
CEDERHOLMWILLIAMS, SA ;
MOORE, J ;
SHOGRY, MEC ;
TURNER, RC .
DIABETOLOGIA, 1984, 27 (05) :493-496
[13]   SYNTHESIS OF FIBRONECTIN BY CULTURED HUMAN ENDOTHELIAL CELLS [J].
JAFFE, EA ;
MOSHER, DF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 147 (06) :1779-1791
[14]   GLOMERULAR THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - PREVALENCE AND SIGNIFICANCE [J].
KANT, KS ;
POLLAK, VE ;
WEISS, MA ;
GLUECK, HI ;
MILLER, MA ;
HESS, EV .
MEDICINE, 1981, 60 (02) :71-86
[16]  
Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2
[17]   2 DIFFERENT MECHANISMS IN PATIENTS WITH VENOUS THROMBOSIS AND DEFECTIVE FIBRINOLYSIS - LOW CONCENTRATION OF PLASMINOGEN-ACTIVATOR OR INCREASED CONCENTRATION OF PLASMINOGEN-ACTIVATOR INHIBITOR [J].
NILSSON, IM ;
LJUNGNER, H ;
TENGBORN, L .
BRITISH MEDICAL JOURNAL, 1985, 290 (6480) :1453-1456
[18]  
NILSSON IM, 1975, PROGR CHEMICAL FIBRI, V1, P1
[19]  
OCONNER NJT, 1984, POSTGRAD MED J, V60, P35
[20]  
OCONNOR NTJ, 1984, BRIT HEART J, V52, P614